FDA NDC Directory · JSON-LD · Markdown

Creon

NDC 0032-0047 · HUMAN PRESCRIPTION DRUG · CAPSULE, DELAYED RELEASE PELLETS

Generic namePancrelipase
Labeler / ManufacturerAbbVie Inc.
Marketing categoryBiologic License Application · App BLA020725
Dosage form / routeCAPSULE, DELAYED RELEASE PELLETS · ORAL
Active ingredientsPANCRELIPASE AMYLASE (60000 [USP'U]/1)
PANCRELIPASE LIPASE (12000 [USP'U]/1)
PANCRELIPASE PROTEASE (38000 [USP'U]/1)
Marketing started20231012
Package count2

External sources

Source: openFDA. Public-domain (CC0).